Eric Merola covers: March 3, 2017 – Texas vs. Burzynski

Full videos and video highlights from trial’s conclusion:

On March 3, 2017, the Texas Medical Board (TMB), and its Board staff concluded their multi-year long attempt to revoke Dr. Burzynski’s medical license. (This is an estimated 20th attempt at this effort since the 1980s).

For a quick explanation on how this works: The TMB’s Board Staff files the complaints and seeks a trial. Once the trial is complete, it is up to the actual TMB, as the “Board” to decide on the final outcome, based on the judges “Finding Of Fact” in their “Proposed Decision”. [Read the entire “Findings of Fact” in the “Proposed Decision here].

While the Board’s Staff sought to revoke Dr. Burzynski’s medical license, they failed. According to the judges, it was found that 94% of the charges against Dr. Burzynski were false, with 6% of the Board’s charges were considered true. But this 6% was based on “documentation issues”, such as bookkeeping errors. Of the non-documentation issues, things that specifically have to do with the actual practice of medicine, the Judges found that 99.996% of the charges were false, with 0.004% being true.

(This the first time you heard about this? Check out the first leg of the trial from November of 2015; and check out the second leg of the trial in May of 2016).

If you wish to view/download the March 3, 2017 March 3, 2017 TMB schedule to follow along, you can read it here.


The morning of March 3, 2017 – patients arrive to protest.

(3:30)

The full “Board Meeting” to discuss the Judges “Findings of Fact”

(1:05:08) March 3, 2017 – Every quarter of the year, the TMB meets to discuss policy and any pending case, this was the day Dr. Burzynski’s case was to be discussed for final decision. Both Dr. Burzynski’s defense attorneys and the TMB Board Staff argued for each side.


The “Final Decision”



(15:21) March 3, 2017 – The TMB discusses and makes the final decision on Dr. Burzynski’s fate.



* At this point in the day, anyone who signed up to “speak” got an opportunity to speak for a maximum of 3 minutes directly to the TMB. These public statements would come after the decision, rendering the statements mute in regards to the case. Nonetheless, 20+ people took the opportunity to speak and have their 3 minutes heard.



Eric Merola speaks to the TMB

Eric Merola (Burzynski Documentary Series Director) speaks to the Texas Medical Board.


Tony Farmer speaks to the TMB

Tony is a resident of Austin, and a long-time supporter of Dr. Burzynski.



Sheila and Coleman Hemphill speak to the TMB

The Hemphill’s are a part of “Texas Right To Know”


Jodi Fenton speaks to the TMB

Jodi Fenton was featured in “Burzynski, the Movie”.

Jodi was cured of a Grade III Anaplastic Astrocytoma brain tumor.




Mary Jo & Steve Siegel speak to the TMB

Mary Jo Siegel was cured of non-Hodgkin’s lymphoma, after refusing a bone marrow transplant.


Carol Bricker speaks to the TMB

Carol was cured of breast cancer.


Lali Fizil speaks to the TMB

Lali’s mother is currently on Antineoplastons for lung cancer.




Magdalena Fizil speaks to the TMB

Magdalena is currently on Antineoplastons for lung cancer.




Mary & Paul Micaels speak to the TMB

<emPaul was cured of an inoperable optic-hypothalamic glioma astrocytoma brain tumor.




The Kunnari family speaks to the TMB

The Kunnari’s were featured in “Burzynski, the Movie”


Brenda & Patrick Powers speak to the TMB

Their son, Patrick, was diagnosed with an anaplastic astrocytoma. Treated by conventional therapy failed. Patrick is currently on Antineoplastons.


Rita Starr speaks to the TMB

Rita became an integral advocate in the 1990’s for Dr. Burzynski – particularly during the federal trials. She did so after Antineoplastons cured her mother of terminal cancer.


Ayub Khaledi speaks to the TMB

Ayub’s 4-year-old daughter is currently on Antineoplastons for an inoperable brain tumor.


Julie Atkins speaks to the TMB

Julie’s friend received Antineoplastons in the early 1990s curing her breast cancer. When Julie was diagnosed with breast cancer she chose Burzynski.


Liv Larsen speaks to the TMBB

Liv is a documentary filmmaker. A child Liv once babysat for was just diagnosed with a DIPG (Diffuse Intrinsic Pontine Glioma), things got personal for Liv.


The Gettino family speaks to the TMB

Sophia was diagnosed at 10.5 months old with a deadly pinealoblastoma brain tumor. Antineoplastons cured her.


Randy Gilbert speaks to the TMB

Kendra was cured of an inoperable grade III anaplastic astrocyoma brain tumor.


Randy Gilbert speaks to the TMB

Kendra was cured of an inoperable grade III anaplastic astrocyoma brain tumor.


dr-b-poignant

young-dr-b-web

Your rental or purchase of this new release helps to support and maintain our ability to keep this story alive and in the public’s eye, only $5.00.


https://embed.vhx.tv/packages/16569


* (November 19-25, 2015) Summary of the first leg of the trial + watch all testimony unedited

* (May 3-13, 2016) Summary of the first leg of the trial + watch all testimony unedited

See the leaked documents and other materials from the documentary “Second Opinion: Laetrile At Sloan-Kettering”

June 2, 1974 Laetrile Meeting with Top Leaders (Minutes)

On June 2, 1974 a meeting was held at The Food & Drug Administration (FDA) headquarters. The meeting’s purpose was to discuss conducting human clinical trials using Laetrile or similar “cyanide-releasing” substances based on the overwhelmingly positive lab studies conducted by Sloan-Kettering’s Dr. Kanematsu Sugiura.

These minutes were obtained via a “Freedom of Information Act” request.

Read: June 2, 1974 Minutes from Laetrile meeting at the FDA

After all attempts to get the attention of  mainstream journalists using these leaked documents, Ralph W. Moss, PhD packaged the documents up and sent them anonymously to “The Committee For Freedom Of Choice In Cancer Therapy” – which continued to distribute them in an attempt to alert the American public of this cover-up.

Read the leaked documents package here.

1977 Second Opinion Special Report: Laetrile At Sloan-Kettering

This 48-page document was written in the summer of 1977 by Ralph W. Moss, PhD and other anonymous rank-in-file employees of Sloan-Kettering. This report was written in response to the alleged “negative” findings of Sloan-Kettering’s Laetrile studies from 1973-1977. This document was also given to all in attendance of the November 1977 press conference held by Second Opinion.

Read the “Second Opinion Special Report: Laetrile At Sloan-Kettering Special” document here.

November 22, 1977 Letter to Second Opinion from Dr. Kanematsu Sugiura

While Ralph W. Moss, PhD was still an anonymous participant in Second Opinion, he sent his evaluation of Sloan-Kettering’s papers on their Laetrile studies (Special Report on Laetrile) to Dr. Sugiura, who was the lead scientist conducting the studies. This letter is Dr. Sugiura’s response to Ralph’s evaluation of his work and how Sloan-Kettering diabolically manipulated the positive data. The letter is addressed to Alec Pruchnicki, the only public “face” of Second Opinion at this time.

Read the Nov. 22, 1977 letter to Second Opinion from Dr. Sugiura

July 30, 1979 letter from Dr. Kanematsu Sugiura

Shortly after the release of this documentary, the film’s director was contacted by a man named John Pittman Hey, who had written to Dr. Sugiura regarding the laetrile cover-up back in 1979—and Dr. Sugiura responded. This is a very special and rare letter, and Mr. Hey has given us permission to post it here. It’s incredible how focused Dr. Sugiura was even at this late age – and how he steadfastly stood behind the results he found while testing Laetrile at Sloan-Kettering. It also shows what kind of man Dr. Sugiura was to write a handwritten 4-page letter to a total stranger. He wrote this letter 3 months before his death.

Read the July 30, 1979 letter from Dr. Sugiura to Mr. Hey

 

October 24, 1979 Letter to Ralph W. Moss, PhD from Linus Pauling

After Ralph was fired for exposing the Laetrile cover-up at Sloan-Kettering, he wrote a book about his experience called The Cancer Rebellion: Hope and Betrayal, that was to eventually become The Cancer Industry. Linus Pauling had some very strong words towards “The War On Cancer”.

Read the letter from Linus Pauling to Ralph W. Moss

1971 Congressional Testimony from the NCI’s Dr. Dean Burk

*This document is not included in Second Opinion, but it gives some insight to the political climate around Laetrile when the War On Cancer was first enacted. This is congressional testimony by Dr. Dean Burk, the head of the National Cancer Institute’s Cytochemistry Sector, with Congressman Symington.

Read the 1971 Congressional Testimony with Dr. Burk and Rep. Symington

 

German studies confirm Laetrile/Amygdalin’s anti-cancer properties

Watch the Q&A from “Second Opinion” here:

 

 

Read the peer-reviewed publications here:

August 2014:

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0105590

 

Amygdalin Influences Bladder Cancer Cell Adhesion and InvasionIn Vitro

October 2014: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0110244

 

Challenge for the reader, try adding these verifiable links to the Wikipedia page for “Amygdalin” – they will not allow it! (Click here).

 

Maybe this is why 🙂 Watch this amazing TEDx lecture below:

 

 

Eric Merola releases “Second Opinion: Laetrile At Sloan-Kettering”

Eric Merola releases “Second Opinion: Laetrile At Sloan-Kettering” in 5 cities theatrically, and not a peep from Sloan-Kettering.

See the Change.org petition.

 

 

WATCH INSTANTLY on VHX for $4.99

Television | Print | Radio

TV:

September 3, 2014
CBS’s internationally syndicated TV show, “The Doctors”

 

September 19, 2014
KATU-TV, Portland, OR – Live interview with Eric Merola and Ralph Moss

[hr]

PRINT REVIEWS:

“Though a documentary, it’s dramatic enough to be reminiscent of ‘The Insider’, the whistleblowing thriller about Big Tobacco.”

—Graham Fuller, New York Daily News August 28, 2014

“Mr. Moss’s message is clear, shrewdly edited and peculiarly interesting.”

—Anita Gates, New York TimesAugust 28, 2014

“an intriguing tale”

—Robert Abele, Los Angeles Times, September 4, 2014

“‘has the production value of a Hollywood whistle-blower thriller”

The Stranger, Seattle WA, September 18, 2014

“‘Second Opinion’ revives stifled testing of cancer drug”

San Francisco Chronicle, September 10, 2014

“unraveling the threads of a contested cancer treatment”

San Francisco Weekly, September 10, 2014

“See this film for a riveting account of the conflicts between corporate power and the public good.”

Counter Punch – August 29, 2014

Interview with Ralph W. Moss and Eric Merola
— Robyn Candyce, Moviehole.net – September 2, 2014 

“Captivating story”
This Week In New York – August 31, 2014

“‘Nobody is going to pay $70,000 for a new cancer drug if they can buy Laetrile for 75 cents.” There you have it.”
Reel Life with Jane – August 31, 2014

“this is a worthy piece of work.”
Hollywood Report Card

“riveting…absorbing study of men who sold out science at a renowned institution” 
Anthony Liversidge, New Movies New York – August 31, 2014

“shocking … eye-opening expose’ confirming your worst fears”
Kam Williams – August 30, 2014

“A fascinating, eye-opening and enraging exposé”
NYC Movie Guru – August 29, 2014

“Disturbing … what happens when language must be turned inside out”
Pop Matters – August 29, 2014

“eye-opening documentary”
Turkish New York, September 9, 2014

“Portrait of a thoughtful, articulate, and courageous whistle-blower.”
Spirituality and Practice – August 28, 2014

Second Opinion reveals something astonishingly tragic in the annals of medical history”
Film Journal International – August 27, 2014

“educate[s] viewers of the immense political and economic control that works to determine
what is considered conventional medicine”

Latino Weekly – August 27, 2014

“Concisely presents an interesting and often overlooked chapter of recent American history”
Tiny Mixed Tapes – August 26, 2014

“This intelligent film … may be a renewed eye on the power of pharmaceuticals and their lobbies.”
It’s Just Movies – August 21, 2014

“Eric Merola delivers a documentary that both inspires and astounds.” 
Stage Buddy – August 19, 2014

“A powerful and enlightening documentary that is sure to resonate with audiences” 
Life In LA – August 14, 2014

[hr]

RADIO:

KSJS FM  – 90.5 FM – Celluloid Dreams – San Jose, CA
September 16, 2014 (Eric Merola ad Ralph Moss)

KGO-AM Review with Andrea Chase, San Francisco
September 16, 2014

97.3 FM interview with Eric Merola and Ralph Moss, Liz Saint John, San Francisco
September 14, 2014

Film School Radio: Los Angeles
September 5, 2014 (Eric Merola)

KPFK-FM Radio: Los Angeles, Santa Barbara, San Diego, Ridgecrest.
September 3, 2014 (Eric Merola)

KGO-AM Radio, San Francisco
September 1, 2014 (Ralph W. Moss)

Dr. Ronald Hoffman Podcast (Part 1 of 2) August 29, 2014

Dr. Ronald Hoffman Podcast (Part 2 of 2) August 29, 2014

Leonard Lopate Radio Show (NPR / WNYU) – New York City
August 27, 2014 (Ralph W. Moss)

LISTEN

Coast2Coast Radio – Worldwide
August 26, 2014 
(Ralph W. Moss)

WSPU / NPR / PBS radio interview with Ralph W. Moss, PhD
May 30, 2014 – State College, PA
[ listen ]

[hr]

MORE:

September 18, 2014
Eric Merola and Ralph W. Moss, PhD on Bulletproof Radio with Dave Asprey

March 6, 2014
Q&A session with Director Eric Merola and Ralph W. Moss, PhD


[hr]

Watch BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II free on HULU!

Watch Burzynski Part II on Hulu!

Watch BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II free on HULU!

http://www.hulu.com/watch/571293

About the film:

In the compelling follow-up to the internationally award-winning documentary, Burzynski, the Movie; Burzynski: Cancer is Serious Business, Part II explores the current status of Antineoplastons’ clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas.

For most patients undergoing Burzynski’s treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many for dead.

As the story unfolds, you will observe a real-time change of hearts and minds from many of these doctors and families. Unlike the first documentary, Part II showcases interviews with board-certified oncologists, surgeons and neurosurgeons, who witnessed patients leave their care, soon to return in great health after opting for the Burzynski Clinic.

Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy which he calls, “Personalized Gene-Targeted Cancer Therapy”, where each patient’s Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient—vs. the conveyor belt, “one-size-fits-all” approach that current oncology adheres to.

Due to the slow-moving, bureaucratic obstacles enforced on Antineoplastons by America’s FDA, this new expanded “personalized gene-targeted” direction has allowed more patients (who are denied access to Antineoplastons) to benefit from Burzynski’s practice in ways never before thought possible. And yet, still with similar resistance and controversy endured by Burzynski’s Antineoplaston therapy.

The film also takes you to Kurume University in Fukuoka, Japan—where independently designed studies of Antineoplastons have been underway for 27 years—without Dr. Burzynski’s (the inventor’s) involvement or supervision. Learn how this team of Japanese pathologists, oncologists and surgeons have studied these anti-cancer co mpounds using their own methodologies—resulting in the first ever independently-run randomized controlled clinical trials.

“After twenty-seven years of independently testing Antineoplastons—including randomized clinical trials, we found that Dr. Burzynski was right. It’s obviously not anecdotal anymore.”
– Hideaki Tsuda, MD – 2013, Kurume Medical University, Fukuoka Prefecture, Japan

You will be placed into the turbulent journey of how the industry utilizes its now usurped regulatory agency to both block Antineoplastons’ Phase 3 clinical trial process—and orchestrate a group of “information hit men” (also known as an “Astroturf Campaign”) to pollute all channels of public information in an effort to confuse the public over the truth behind Antineoplastons. This international Astroturf group also engages in the intimidation and harassment of prospective and current terminal cancer patients under Dr. Burzynski’s care.

However, most notable of all—are the earth-shattering events that occurred upon the final days of production of this film—you’ll be left speechless, yet with so much to say, when you witness the story and shocking conclusion to Burzynski: Cancer Is Serious Business, Part II.

“I can’t imagine a world where other people will not have the privilege that I have had—the privilege to have their life saved by a new technology that can cure cancer—it’s terrifying.”

– Laura Hymas – 2013, Glioblastoma Grade IV brain cancer patient, after experiencing a complete remission under Antineoplaston therapy.

 

Follow director Eric Merola on Facebook

 

Eric Merola interviews former National Cancer Institute Scientist Dr. Li-Chuan Chen (VIDEO)

Eric Merola interviews former National Cancer Institute Scientist Dr. Li-Chuan Chen

Dr. Chen, formerly of the National Cancer Institute talks candidly about his work on Antineoplastons at the NCI, and his idea of our society needing a 2-party medical system for any real progress to be made in the War On Cancer.